Dr. Doron Ringler is a Cresskill, New Jersey based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 300 Knickerbocker Rd, Suite 2000, Cresskill. Patients can reach him at 201-399-7707.
Dr. Doron Ringler deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Doron Ringler speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Doron Ringler
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
DMD, MD
Accepts Medicare Assignment:
May Accept
Practice Address:
300 Knickerbocker Rd, Suite 2000, Cresskill, New Jersey, 07626-1350
Phone:
201-399-7707
Fax:
201-399-7711
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
9032424122
Enrollment ID:
I20160729000882
NPI Number:
1336339829
NPI Enumeration Date:
31 Jul, 2007
NPI Last Update On:
11 Mar, 2014
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
300 Knickerbocker Rd, Suite 2000 Cresskill, New Jersey
Zip:
07626-1350
Phone Number:
201-399-7707
Fax Number:
201-399-7711
Patients can reach Dr. Doron Ringler at 300 Knickerbocker Rd, Suite 2000, Cresskill, New Jersey or can call to book an appointment on 201-399-7707. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.